このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Mednow マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

Recent updates

Is Mednow (CVE:MNOW) In A Good Position To Deliver On Growth Plans?

Jun 24

We're Hopeful That Mednow (CVE:MNOW) Will Use Its Cash Wisely

Mar 11

CEO（最高経営責任者

Mednow CEOがいない、あるいは彼らに関するデータがない。

Mednow マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Mednow Announces Executive Changes

Mednow Announces Board Member Resignations

Mednow Inc. Announces CEO Changes

Mednow Inc., Annual General Meeting, Jun 07, 2022

Mednow Inc. Appoints Carey Lai as Director of Pharmacy Operations

Recent updates

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Notice Received from Secured Creditor

Mednow Announces Executive Changes

Mednow Inc. announced that it has received CAD 0.85 million in funding

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Inc. Announces the Execution of Cost Reductions Through the Wind-Down of A Subsidiary

Mednow Announces Board Member Resignations

Mednow Inc. announced that it has received CAD 0.4 million in funding

Mednow Inc. announced that it expects to receive CAD 0.4 million in funding

Third quarter 2023 earnings released: CA$0.19 loss per share (vs CA$0.26 loss in 3Q 2022)

Mednow Inc. announced that it expects to receive CAD 0.585 million in funding

Mednow Inc. has completed a Composite Units Offering in the amount of CAD 0.525262 million.

Second quarter 2023 earnings released: CA$0.20 loss per share (vs CA$0.26 loss in 2Q 2022)

Mednow Inc. Supports Expanded Scope of Practice for Ontario Pharmacists

First quarter 2023 earnings released

Mednow Inc. Expands Suite of Services

Full year 2022 earnings released: CA$1.37 loss per share (vs CA$0.49 loss in FY 2021)

Mednow Inc. Announces CEO Changes

Third quarter 2022 earnings released

Mednow Inc. Provides Earnings Guidance for the Third Quarter of Fiscal Year Ending April 30, 2022

Mednow Inc., Annual General Meeting, Jun 07, 2022

Mednow Inc. (TSXV:MNOW) completed the acquisition of Mednow East Inc. from Amir Ali Reyhany-Bozorg, Felipe Campusano and Karim Nassar and others.

Mednow Inc. Provides Earnings Guidance for the Years of 2022 and 2023

Mednow Inc. (TSXV:MNOW) completed the acquisition of Liver Care Canada Inc.

Mednow Inc. (TSXV:MNOW) entered into a share purchase agreement to acquire London Pharmacare Inc. from Felipe Campusano and others for CAD 0.59 million.

Mednow Inc. (TSXV:MNOW) entered into an agreement to acquire Liver Care Canada Inc. for CAD 0.07 million.

Mednow Inc. (TSXV:MNOW) completed the acquisition of Infusicare Canada Inc. from Amir Ali Reyany-Bozorg, Felipe Campusano and others for CAD 1.9 million.

Mednow Inc. (TSXV:MNOW) entered into a share purchase agreement to acquire Mednow Pharmacy Inc. from Amir Ali Reyhany-Bozorg, Karim Nassar and Felipe Campusano for CAD 0.074 million.

Mednow Inc. (TSXV:MNOW) acquired 2716725 Ontario Inc. for CAD 2 million.

Is Mednow (CVE:MNOW) In A Good Position To Deliver On Growth Plans?

Chief Financial Officer Joshua Lebovic has left the company

Mednow Inc. Appoints Carey Lai as Director of Pharmacy Operations

We're Hopeful That Mednow (CVE:MNOW) Will Use Its Cash Wisely

CEO（最高経営責任者

マネジメント基準チェック /04